{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:59:11Z","timestamp":1789394351762,"version":"build-2803163510"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-023-02277-2","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T11:02:26Z","timestamp":1704884546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["A comprehensive review on the applications of ferrite nanoparticles in the diagnosis and treatment of breast cancer"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2407-1503","authenticated-orcid":false,"given":"Muhammad Furqan","family":"Akhtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysha","family":"Afzaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammara","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Roheel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Imran","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,10]]},"reference":[{"issue":"8","key":"2277_CR1","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/00914037.2020.1869737","volume":"71","author":"MZ Ahmad","year":"2022","unstructured":"Ahmad MZ, et al. Progress in nanomedicine-based drug delivery in designing of chitosan nanoparticles for cancer therapy. Int J Polym Mater Polym Biomater. 2022;71(8):602\u201323.","journal-title":"Int J Polym Mater Polym Biomater"},{"key":"2277_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2021.116291","volume":"141","author":"R Eivazzadeh-Keihan","year":"2021","unstructured":"Eivazzadeh-Keihan R, et al. Functionalized magnetic nanoparticles for the separation and purification of proteins and peptides. Trends Anal Chem. 2021;141: 116291.","journal-title":"Trends Anal Chem"},{"issue":"1","key":"2277_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1124\/pr.112.005660","volume":"65","author":"HD Williams","year":"2013","unstructured":"Williams HD, et al. Strategies to address low drug solubility in discovery and development. Pharmacol Rev. 2013;65(1):315\u2013499.","journal-title":"Pharmacol Rev"},{"issue":"2","key":"2277_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jconrel.2011.09.063","volume":"161","author":"T Lammers","year":"2012","unstructured":"Lammers T, et al. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J Control Release. 2012;161(2):175\u201387.","journal-title":"J Control Release"},{"issue":"44","key":"2277_CR5","doi-asserted-by":"publisher","first-page":"17560","DOI":"10.1021\/ja207150n","volume":"133","author":"J-Z Du","year":"2011","unstructured":"Du J-Z, et al. Tailor-made dual pH-sensitive polymer\u2013doxorubicin nanoparticles for efficient anticancer drug delivery. J Am Chem Soc. 2011;133(44):17560\u20133.","journal-title":"J Am Chem Soc"},{"issue":"8","key":"2277_CR6","doi-asserted-by":"publisher","first-page":"836","DOI":"10.2174\/138920009790274540","volume":"10","author":"C-MJ Hu","year":"2009","unstructured":"Hu C-MJ, Zhang L. Therapeutic nanoparticles to combat cancer drug resistance. Curr Drug Metab. 2009;10(8):836\u201341.","journal-title":"Curr Drug Metab"},{"issue":"29","key":"2277_CR7","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1016\/j.vaccine.2022.05.068","volume":"40","author":"B Wilson","year":"2022","unstructured":"Wilson B, Geetha KM. Nanomedicine to deliver biological macromolecules for treating COVID-19. Vaccine. 2022;40(29):3931\u201341.","journal-title":"Vaccine"},{"issue":"1\u20133","key":"2277_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cej.2006.11.001","volume":"129","author":"DS Mathew","year":"2007","unstructured":"Mathew DS, Juang R-S. An overview of the structure and magnetism of spinel ferrite nanoparticles and their synthesis in microemulsions. Chem Eng J. 2007;129(1\u20133):51\u201365.","journal-title":"Chem Eng J"},{"issue":"1","key":"2277_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.10.021","volume":"331","author":"J Kreuter","year":"2007","unstructured":"Kreuter J. Nanoparticles\u2014a historical perspective. Int J Pharm. 2007;331(1):1\u201310.","journal-title":"Int J Pharm"},{"key":"2277_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cis.2019.01.003","volume":"265","author":"M Amiri","year":"2019","unstructured":"Amiri M, Salavati-Niasari M, Akbari A. Magnetic nanocarriers: evolution of spinel ferrites for medical applications. Adv Coll Interface Sci. 2019;265:29\u201344.","journal-title":"Adv Coll Interface Sci"},{"issue":"2","key":"2277_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/19430892.2012.676918","volume":"4","author":"R Srivastava","year":"2012","unstructured":"Srivastava R, Yadav BC. Ferrite materials: introduction, synthesis techniques, and applications as sensors. Int J Green Nanotechnol. 2012;4(2):141\u201354.","journal-title":"Int J Green Nanotechnol"},{"issue":"7","key":"2277_CR12","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.arabjc.2014.10.049","volume":"12","author":"BI Kharisov","year":"2019","unstructured":"Kharisov BI, Dias HR, Kharissova OV. Mini-review: ferrite nanoparticles in the catalysis. Arab J Chem. 2019;12(7):1234\u201346.","journal-title":"Arab J Chem"},{"issue":"6","key":"2277_CR13","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1039\/C3CP54257B","volume":"16","author":"SE Shirsath","year":"2014","unstructured":"Shirsath SE, et al. Self-ignited high temperature synthesis and enhanced super-exchange interactions of Ho3+\u2013Mn2+\u2013Fe3+\u2013O2\u2212 ferromagnetic nanoparticles. Phys Chem Chem Phys. 2014;16(6):2347\u201357.","journal-title":"Phys Chem Chem Phys"},{"issue":"4","key":"2277_CR14","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1016\/j.ceramint.2019.10.237","volume":"46","author":"MA Rafiq","year":"2020","unstructured":"Rafiq MA, et al. Understanding the structural, electronic, magnetic and optical properties of spinel MFe2O4 (M = Mn Co, Ni) ferrites. Ceram Int. 2020;46(4):4976\u201383.","journal-title":"Ceram Int"},{"issue":"32","key":"2277_CR15","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/ab8cf2","volume":"31","author":"A Meidanchi","year":"2020","unstructured":"Meidanchi A. Mg (1\u2013x) CuxFe2O4 superparamagnetic nanoparticles as nano-radiosensitizer agents in radiotherapy of MCF-7 human breast cancer cells. Nanotechnology. 2020;31(32): 325706.","journal-title":"Nanotechnology"},{"key":"2277_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2023.136836","volume":"1296","author":"T Karan","year":"2024","unstructured":"Karan T, et al. Green synthesis of silver nanoparticles using Sambucus ebulus leaves extract: characterization, quantitative analysis of bioactive molecules, antioxidant and antibacterial activities. J Mol Struct. 2024;1296: 136836.","journal-title":"J Mol Struct"},{"key":"2277_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtcomm.2023.105863","volume":"35","author":"R Erenler","year":"2023","unstructured":"Erenler R, Hosaflioglu I. Green synthesis of silver nanoparticles using Onobrychis sativa L.: characterization, catalytic degradation of methylene blue, antioxidant activity, and quantitative analysis of bioactive compounds. Mater Today Commun. 2023;35: 105863.","journal-title":"Mater Today Commun"},{"issue":"1","key":"2277_CR18","doi-asserted-by":"publisher","first-page":"20228126","DOI":"10.1515\/gps-2022-8126","volume":"12","author":"EN Gecer","year":"2023","unstructured":"Gecer EN. Synthesis and characterization of silver nanoparticles using Origanum onites leaves: cytotoxic, apoptotic, and necrotic effects on Capan-1, L929, and Caco-2 cell lines. Green Process Synth. 2023;12(1):20228126.","journal-title":"Green Process Synth"},{"issue":"5","key":"2277_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jics.2023.101003","volume":"100","author":"EN Gecer","year":"2023","unstructured":"Gecer EN, Erenler R. Biogenic synthesis of silver nanoparticles using Echium vulgare: characterisation, quantitative analysis of bioactive compounds, antioxidant activity and catalytic degradation. J Indian Chem Soc. 2023;100(5): 101003.","journal-title":"J Indian Chem Soc"},{"issue":"5","key":"2277_CR20","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s41779-023-00917-4","volume":"59","author":"M Kurian","year":"2023","unstructured":"Kurian M. Green synthesis routes for spinel ferrite nanoparticles: a short review on the recent trends. J Aust Ceram Soc. 2023;59(5):1161\u201375.","journal-title":"J Aust Ceram Soc"},{"issue":"22","key":"2277_CR21","doi-asserted-by":"publisher","first-page":"9175","DOI":"10.1158\/0008-5472.CAN-10-1318","volume":"70","author":"P de Souza Rocha Simonini","year":"2010","unstructured":"de Souza Rocha Simonini P, et al. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor \u03b1 in breast cancer cells. Cancer Res. 2010;70(22):9175\u201384.","journal-title":"Cancer Res"},{"issue":"15","key":"2277_CR22","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1158\/1078-0432.CCR-19-0173","volume":"25","author":"AG Waks","year":"2019","unstructured":"Waks AG, et al. The immune microenvironment in hormone receptor-positive breast cancer before and after preoperative chemotherapyimmune microenvironment in HR+ breast cancer. Clin Cancer Res. 2019;25(15):4644\u201355.","journal-title":"Clin Cancer Res"},{"key":"2277_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.phrs.2018.11.014","volume":"139","author":"R Roskoski Jr","year":"2019","unstructured":"Roskoski R Jr. Small molecule inhibitors targeting the EGFR\/ErbB family of protein-tyrosine kinases in human cancers. Pharmacol Res. 2019;139:395\u2013411.","journal-title":"Pharmacol Res"},{"issue":"14","key":"2277_CR24","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1158\/1078-0432.CCR-16-2026","volume":"23","author":"AC Degnim","year":"2017","unstructured":"Degnim AC, et al. Alterations in the immune cell composition in premalignant breast tissue that precede breast cancer developmentimmune cells and premalignant breast tissue. Clin Cancer Res. 2017;23(14):3945\u201352.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"2277_CR25","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.7314\/APJCP.2014.15.12.4745","volume":"15","author":"AR Nourazarian","year":"2014","unstructured":"Nourazarian AR, Kangari P, Salmaninejad A. Roles of oxidative stress in the development and progression of breast cancer. Asian Pac J Cancer Prev. 2014;15(12):4745\u201351.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2277_CR26","doi-asserted-by":"publisher","DOI":"10.15761\/ICST.1000228","author":"I Godet","year":"2017","unstructured":"Godet I, Gilkes DM. BRCA1 and BRCA2 mutations and treatment strategies for breast cancer. Integr Cancer Sci Ther. 2017. https:\/\/doi.org\/10.15761\/ICST.1000228.","journal-title":"Integr Cancer Sci Ther"},{"issue":"4","key":"2277_CR27","doi-asserted-by":"publisher","first-page":"571","DOI":"10.4103\/0019-509X.175345","volume":"51","author":"U Kapil","year":"2014","unstructured":"Kapil U, et al. Reproductive factors and risk of breast cancer: a review. Indian J Cancer. 2014;51(4):571.","journal-title":"Indian J Cancer"},{"issue":"2","key":"2277_CR28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2231-4040.72251","volume":"1","author":"GN Sharma","year":"2010","unstructured":"Sharma GN, et al. Various types and management of breast cancer: an overview. J Adv Pharm Technol Res. 2010;1(2):109.","journal-title":"J Adv Pharm Technol Res"},{"key":"2277_CR29","first-page":"135","volume":"321","author":"G Batyrova","year":"2021","unstructured":"Batyrova G, et al. Air pollution emissions are associated with incidence and prevalence of breast cancer in the aktobe region of western Kazakhstan. Georgian Med News. 2021;321:135\u201340.","journal-title":"Georgian Med News"},{"issue":"1","key":"2277_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.soc.2017.08.004","volume":"27","author":"LN Chaudhary","year":"2018","unstructured":"Chaudhary LN, Wilkinson KH, Kong A. Triple-negative breast cancer: who should receive neoadjuvant chemotherapy? Surg Oncol Clin. 2018;27(1):141\u201353.","journal-title":"Surg Oncol Clin"},{"key":"2277_CR31","doi-asserted-by":"crossref","unstructured":"Kumari N, et al. A brief review on synthesis, properties and applications of ferrites. In: AIP conference proceedings. 2020. AIP Publishing LLC.","DOI":"10.1063\/5.0001323"},{"key":"2277_CR32","doi-asserted-by":"crossref","unstructured":"Garcia-Mu\u00f1oz P, et al. Ferrite materials for photoassisted environmental and solar fuels applications. Heterogeneous Photocatal 2020;107\u2013162.","DOI":"10.1007\/978-3-030-49492-6_4"},{"key":"2277_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.hazadv.2022.100150","volume":"8","author":"E Sarala","year":"2022","unstructured":"Sarala E, et al. Green synthesis of nickel ferrite nanoparticles using Terminalia catappa: structural, magnetic and anticancer studies against MCF-7 cell lines. J Hazard Mater Adv. 2022;8: 100150.","journal-title":"J Hazard Mater Adv"},{"issue":"6","key":"2277_CR34","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s11051-012-0873-x","volume":"14","author":"LI Cabrera","year":"2012","unstructured":"Cabrera LI, et al. Synthesis and surface modification of uniform MFe2O4 (M = Fe, Mn, and Co) nanoparticles with tunable sizes and functionalities. J Nanopart Res. 2012;14(6):873.","journal-title":"J Nanopart Res"},{"issue":"7","key":"2277_CR35","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/s17071572","volume":"17","author":"L Wang","year":"2017","unstructured":"Wang L. Early diagnosis of breast cancer. Sensors. 2017;17(7):1572.","journal-title":"Sensors"},{"issue":"2","key":"2277_CR36","first-page":"241","volume":"37","author":"GI Andreea","year":"2011","unstructured":"Andreea GI, et al. The role of imaging techniques in diagnosis of breast cancer. Curr Health Sci J. 2011;37(2):241\u20138.","journal-title":"Curr Health Sci J"},{"key":"2277_CR37","first-page":"S50","volume":"47","author":"JM Arshad","year":"2021","unstructured":"Arshad JM, et al. Synthesis and characterization of cobalt ferrites as MRI contrast agent. Mater Today. 2021;47:S50\u20134.","journal-title":"Mater Today"},{"issue":"3","key":"2277_CR38","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1021\/acs.chemrev.6b00073","volume":"117","author":"BR Smith","year":"2017","unstructured":"Smith BR, Gambhir SS. Nanomaterials for in vivo imaging. Chem Rev. 2017;117(3):901\u201386.","journal-title":"Chem Rev"},{"issue":"4","key":"2277_CR39","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1093\/pm\/pnx267","volume":"19","author":"S Shen","year":"2018","unstructured":"Shen S, et al. Ultrasmall superparamagnetic iron oxide imaging identifies tissue and nerve inflammation in pain conditions. Pain Med. 2018;19(4):686\u201392.","journal-title":"Pain Med"},{"issue":"2","key":"2277_CR40","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1021\/acs.chemrev.8b00363","volume":"119","author":"J Wahsner","year":"2018","unstructured":"Wahsner J, et al. Chemistry of MRI contrast agents: current challenges and new frontiers. Chem Rev. 2018;119(2):957\u20131057.","journal-title":"Chem Rev"},{"issue":"11","key":"2277_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1109\/TMAG.2018.2845132","volume":"54","author":"D Shigeoka","year":"2018","unstructured":"Shigeoka D, et al. Functionalization and magnetic relaxation of ferrite nanoparticles for theranostics. IEEE Trans Magn. 2018;54(11):1\u20137.","journal-title":"IEEE Trans Magn"},{"issue":"4","key":"2277_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4103\/jmss.JMSS_59_18","volume":"9","author":"T Sobhani","year":"2019","unstructured":"Sobhani T, et al. Assessment of manganese-zinc ferrite nanoparticles as a novel magnetic resonance imaging contrast agent for the detection of 4T1 breast cancer cells. J Med Signals Sens. 2019;9(4):245.","journal-title":"J Med Signals Sens"},{"key":"2277_CR43","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jmmm.2016.05.063","volume":"417","author":"S Bano","year":"2016","unstructured":"Bano S, et al. Biopolymers coated superparamagnetic nickel ferrites: enhanced biocompatibility and MR imaging probe for breast cancer. J Magn Magn Mater. 2016;417:284\u201390.","journal-title":"J Magn Magn Mater"},{"key":"2277_CR44","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.addr.2018.12.007","volume":"138","author":"JW Bulte","year":"2019","unstructured":"Bulte JW. Superparamagnetic iron oxides as MPI tracers: a primer and review of early applications. Adv Drug Deliv Rev. 2019;138:293\u2013301.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"2277_CR45","doi-asserted-by":"publisher","first-page":"18682","DOI":"10.3390\/ijms140918682","volume":"14","author":"Y Du","year":"2013","unstructured":"Du Y, et al. Design of superparamagnetic nanoparticles for magnetic particle imaging (MPI). Int J Mol Sci. 2013;14(9):18682\u2013710.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2277_CR46","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3390\/pharmaceutics13070943","volume":"13","author":"DD Stueber","year":"2021","unstructured":"Stueber DD, et al. Magnetic nanoparticles in biology and medicine: past, present, and future trends. Pharmaceutics. 2021;13(7):943.","journal-title":"Pharmaceutics"},{"issue":"20","key":"2277_CR47","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.3390\/cancers14205150","volume":"14","author":"F Vurro","year":"2022","unstructured":"Vurro F, et al. Doped ferrite nanoparticles exhibiting self-regulating temperature as magnetic fluid hyperthermia antitumoral agents, with diagnostic capability in magnetic resonance imaging and magnetic particle imaging. Cancers. 2022;14(20):5150.","journal-title":"Cancers"},{"issue":"6","key":"2277_CR48","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1021\/acs.nanolett.9b00630","volume":"19","author":"Y Du","year":"2019","unstructured":"Du Y, et al. Optimization and design of magnetic ferrite nanoparticles with uniform tumor distribution for highly sensitive MRI\/MPI performance and improved magnetic hyperthermia therapy. Nano Lett. 2019;19(6):3618\u201326.","journal-title":"Nano Lett"},{"issue":"5","key":"2277_CR49","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/bjc.1986.239","volume":"54","author":"J Kemshead","year":"1986","unstructured":"Kemshead J, et al. Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: experiences, improvements and observations. Br J Cancer. 1986;54(5):771\u20138.","journal-title":"Br J Cancer"},{"issue":"4","key":"2277_CR50","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.drudis.2013.10.005","volume":"19","author":"A Singh","year":"2014","unstructured":"Singh A, Sahoo SKJDDT. Magnetic nanoparticles: a novel platform for cancer theranostics. Drug Discov Today. 2014;19(4):474\u201381.","journal-title":"Drug Discov Today"},{"issue":"4","key":"2277_CR51","doi-asserted-by":"publisher","DOI":"10.1088\/1361-665X\/abeaeb","volume":"30","author":"D Cohn","year":"2021","unstructured":"Cohn D, et al. Remotely triggered morphing behavior of additively manufactured thermoset polymer-magnetic nanoparticle composite structures. Smart Mater Struct. 2021;30(4): 045022.","journal-title":"Smart Mater Struct"},{"issue":"5","key":"2277_CR52","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1039\/C4LC01246A","volume":"15","author":"CW Shields IV","year":"2015","unstructured":"Shields CW IV, Reyes CD, L\u00f3pez GP. Microfluidic cell sorting: a review of the advances in the separation of cells from debulking to rare cell isolation. Lab Chip. 2015;15(5):1230\u201349.","journal-title":"Lab Chip"},{"issue":"6","key":"2277_CR53","doi-asserted-by":"publisher","first-page":"1700625","DOI":"10.1002\/biot.201700625","volume":"13","author":"K-J Kim","year":"2018","unstructured":"Kim K-J, et al. Subtyping of magnetically isolated breast cancer cells using magnetic force microscopy. Biotechnol J. 2018;13(6):1700625.","journal-title":"Biotechnol J"},{"issue":"Supplement 1","key":"2277_CR54","doi-asserted-by":"publisher","first-page":"9S","DOI":"10.2967\/jnumed.115.157834","volume":"57","author":"ES McDonald","year":"2016","unstructured":"McDonald ES, et al. Clinical diagnosis and management of breast cancer. J Nucl Med. 2016;57(Supplement 1):9S-16S.","journal-title":"J Nucl Med"},{"issue":"19","key":"2277_CR55","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","volume":"377","author":"H Pan","year":"2017","unstructured":"Pan H, et al. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N Engl J Med. 2017;377(19):1836\u201346.","journal-title":"N Engl J Med"},{"issue":"4","key":"2277_CR56","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.annonc.2022.01.009","volume":"33","author":"C Geyer","year":"2022","unstructured":"Geyer C, et al. Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from brightness, a randomized phase III trial. Ann Oncol. 2022;33(4):384\u201394.","journal-title":"Ann Oncol"},{"key":"2277_CR57","first-page":"449","volume":"7","author":"LC Brown","year":"2015","unstructured":"Brown LC, Mutter RW, Halyard MY. Benefits, risks, and safety of external beam radiation therapy for breast cancer. Int J Women\u2019s Health. 2015;7:449.","journal-title":"Int J Women\u2019s Health"},{"issue":"3","key":"2277_CR58","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321(3):288\u2013300.","journal-title":"JAMA"},{"issue":"5","key":"2277_CR59","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3390\/pharmaceutics14050937","volume":"14","author":"SR Mokhosi","year":"2022","unstructured":"Mokhosi SR, et al. Advances in the synthesis and application of magnetic ferrite nanoparticles for cancer therapy. Pharmaceutics. 2022;14(5):937.","journal-title":"Pharmaceutics"},{"issue":"1","key":"2277_CR60","first-page":"326","volume":"11","author":"BS Kalal","year":"2017","unstructured":"Kalal BS, Upadhya D, Pai VR. Chemotherapy resistance mechanisms in advanced skin cancer. Oncol Rev. 2017;11(1):326.","journal-title":"Oncol Rev"},{"issue":"2","key":"2277_CR61","doi-asserted-by":"publisher","first-page":"865s","DOI":"10.1158\/1078-0432.865s.11.2","volume":"11","author":"CK Osborne","year":"2005","unstructured":"Osborne CK, et al. Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin Cancer Res. 2005;11(2):865s\u201370s.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2277_CR62","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/onc.2012.130","volume":"32","author":"B Luo","year":"2013","unstructured":"Luo B, Lee AS. The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies. Oncogene. 2013;32(7):805\u201318.","journal-title":"Oncogene"},{"key":"2277_CR63","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.virusres.2018.01.003","volume":"246","author":"A Cruz-Gregorio","year":"2018","unstructured":"Cruz-Gregorio A, Manzo-Merino J, Lizano M. Cellular redox, cancer and human papillomavirus. Virus Res. 2018;246:35\u201345.","journal-title":"Virus Res"},{"key":"2277_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.651053","volume":"9","author":"S Yu","year":"2021","unstructured":"Yu S, et al. Ferrite nanoparticles-based reactive oxygen species-mediated cancer therapy. Front Chem. 2021;9: 651053.","journal-title":"Front Chem"},{"issue":"42","key":"2277_CR65","doi-asserted-by":"publisher","first-page":"2002439","DOI":"10.1002\/adma.202002439","volume":"32","author":"S Dong","year":"2020","unstructured":"Dong S, et al. GSH-depleted nanozymes with hyperthermia-enhanced dual enzyme-mimic activities for tumor nanocatalytic therapy. Adv Mater. 2020;32(42):2002439.","journal-title":"Adv Mater"},{"key":"2277_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102680","volume":"65","author":"S Hatamie","year":"2021","unstructured":"Hatamie S, et al. Hyperthermia of breast cancer tumor using graphene oxide-cobalt ferrite magnetic nanoparticles in mice. J Drug Deliv Sci Technol. 2021;65: 102680.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"17","key":"2277_CR67","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.3390\/molecules27175451","volume":"27","author":"C Abe","year":"2022","unstructured":"Abe C, Miyazawa T, Miyazawa T. Current use of fenton reaction in drugs and food. Molecules. 2022;27(17):5451.","journal-title":"Molecules"},{"issue":"29","key":"2277_CR68","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.2217\/nnm-2020-0313","volume":"15","author":"DA Fagundes","year":"2020","unstructured":"Fagundes DA, et al. Radiosensitizing effects of citrate-coated cobalt and nickel ferrite nanoparticles on breast cancer cells. Nanomedicine. 2020;15(29):2823\u201336.","journal-title":"Nanomedicine"},{"issue":"3","key":"2277_CR69","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1049\/iet-nbt.2016.0007","volume":"11","author":"N Nordin","year":"2017","unstructured":"Nordin N, et al. Characterisation of sol\u2013gel method synthesised MgZnFe 2 O 4 nanoparticles and its cytotoxic effects on breast cancer cell line, MDA MB-231 in vitro. IET Nanobiotechnol. 2017;11(3):343\u20138.","journal-title":"IET Nanobiotechnol"},{"key":"2277_CR70","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1155\/2013\/865024","volume":"2013","author":"S Kanagesan","year":"2013","unstructured":"Kanagesan S, et al. Cytotoxic effect of nanocrystalline MgFe2O4 particles for cancer cure. J Nanomater. 2013;2013:165.","journal-title":"J Nanomater"},{"issue":"12","key":"2277_CR71","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1021\/acsbiomaterials.6b00333","volume":"2","author":"SM Ansari","year":"2016","unstructured":"Ansari SM, et al. Size and chemistry controlled cobalt-ferrite nanoparticles and their anti-proliferative effect against the MCF-7 breast cancer cells. ACS Biomater Sci Eng. 2016;2(12):2139\u201352.","journal-title":"ACS Biomater Sci Eng"},{"issue":"11","key":"2277_CR72","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.3390\/nano10112310","volume":"10","author":"M Salimi","year":"2020","unstructured":"Salimi M, et al. Treatment of breast cancer-bearing BALB\/c mice with magnetic hyperthermia using dendrimer functionalized iron-oxide nanoparticles. Nanomaterials. 2020;10(11):2310.","journal-title":"Nanomaterials"},{"key":"2277_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103391","volume":"72","author":"N Alamer","year":"2022","unstructured":"Alamer N, et al. Synergizing effects of chemodynamic therapy and chemotherapy against breast cancer by oxaliplatin-loaded polydopamine\/BSA@ copper ferrite. J Drug Deliv Sci Technol. 2022;72: 103391.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"2277_CR74","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jmmm.2005.02.074","volume":"293","author":"M Sincai","year":"2005","unstructured":"Sincai M, et al. Antitumor effect of magnetite nanoparticles in cat mammary adenocarcinoma. J Magn Magn Mater. 2005;293(1):438\u201341.","journal-title":"J Magn Magn Mater"},{"issue":"1\u20132","key":"2277_CR75","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0304-8853(00)01263-4","volume":"225","author":"M \u015eincai","year":"2001","unstructured":"\u015eincai M, et al. The antitumor effect of locoregional magnetic cobalt ferrite in dog mammary adenocarcinoma. J Magn Magn Mater. 2001;225(1\u20132):235\u201340.","journal-title":"J Magn Magn Mater"},{"key":"2277_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.117631","volume":"257","author":"M Abasalta","year":"2021","unstructured":"Abasalta M, et al. Fabrication of carboxymethyl chitosan\/poly (\u03b5-caprolactone)\/doxorubicin\/nickel ferrite core-shell fibers for controlled release of doxorubicin against breast cancer. Carbohydr Polym. 2021;257: 117631.","journal-title":"Carbohydr Polym"},{"issue":"01","key":"2277_CR77","doi-asserted-by":"publisher","first-page":"086","DOI":"10.7324\/JAPS.2017.70111","volume":"7","author":"AS Hathout","year":"2017","unstructured":"Hathout AS, et al. Synthesis and characterization of cobalt ferrites nanoparticles with cytotoxic and antimicrobial properties. J Appl Pharm Sci. 2017;7(01):086\u201392.","journal-title":"J Appl Pharm Sci"},{"key":"2277_CR78","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jmmm.2016.05.061","volume":"417","author":"V Sawant","year":"2016","unstructured":"Sawant V, et al. Comparison of drug delivery potentials of surface functionalized cobalt and zinc ferrite nanohybrids for curcumin in to MCF-7 breast cancer cells. J Magn Magn Mater. 2016;417:222\u20139.","journal-title":"J Magn Magn Mater"},{"key":"2277_CR79","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.colsurfb.2016.02.043","volume":"142","author":"M Ahamed","year":"2016","unstructured":"Ahamed M, et al. Copper ferrite nanoparticle-induced cytotoxicity and oxidative stress in human breast cancer MCF-7 cells. Colloids Surf B. 2016;142:46\u201354.","journal-title":"Colloids Surf B"},{"issue":"1","key":"2277_CR80","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1039\/C4TB01098A","volume":"3","author":"BP Kumar","year":"2015","unstructured":"Kumar BP, et al. Sequential release of drugs from hollow manganese ferrite nanocarriers for breast cancer therapy. J Mater Chem B. 2015;3(1):90\u2013101.","journal-title":"J Mater Chem B"},{"key":"2277_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2019.110314","volume":"107","author":"KK Kefeni","year":"2020","unstructured":"Kefeni KK, et al. Spinel ferrite nanoparticles and nanocomposites for biomedical applications and their toxicity. Mater Sci Eng C. 2020;107: 110314.","journal-title":"Mater Sci Eng C"},{"issue":"1","key":"2277_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.msec.2012.09.003","volume":"33","author":"S Amiri","year":"2013","unstructured":"Amiri S, Shokrollahi H. The role of cobalt ferrite magnetic nanoparticles in medical science. Mater Sci Eng C. 2013;33(1):1\u20138.","journal-title":"Mater Sci Eng C"},{"key":"2277_CR83","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.electacta.2015.06.108","volume":"183","author":"S Matsuda","year":"2015","unstructured":"Matsuda S, et al. Synthesis of cobalt ferrite nanoparticles using spermine and their effect on death in human breast cancer cells under an alternating magnetic field. Electrochim Acta. 2015;183:153\u20139.","journal-title":"Electrochim Acta"},{"issue":"8","key":"2277_CR84","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3109\/1061186X.2016.1157883","volume":"24","author":"W Liu","year":"2016","unstructured":"Liu W, et al. Oral bioavailability of curcumin: problems and advancements. J Drug Target. 2016;24(8):694\u2013702.","journal-title":"J Drug Target"},{"issue":"1","key":"2277_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-018-0392-8","volume":"16","author":"JK Patra","year":"2018","unstructured":"Patra JK, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018;16(1):1\u201333.","journal-title":"J Nanobiotechnol"},{"key":"2277_CR86","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.6b00190","volume-title":"Does nanomedicine have a delivery problem?","author":"M Torrice","year":"2016","unstructured":"Torrice M. Does nanomedicine have a delivery problem? Washington: ACS Publications; 2016."},{"issue":"6","key":"2277_CR87","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1208\/s12248-015-9814-9","volume":"17","author":"H Wen","year":"2015","unstructured":"Wen H, Jung H, Li X. Drug delivery approaches in addressing clinical pharmacology-related issues: opportunities and challenges. AAPS J. 2015;17(6):1327\u201340.","journal-title":"AAPS J"},{"issue":"1","key":"2277_CR88","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jsps.2017.10.012","volume":"26","author":"SA Rizvi","year":"2018","unstructured":"Rizvi SA, Saleh AM. Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J. 2018;26(1):64\u201370.","journal-title":"Saudi Pharm J"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02277-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-023-02277-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02277-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T20:39:53Z","timestamp":1731011993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-023-02277-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":88,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["2277"],"URL":"https:\/\/doi.org\/10.1007\/s12032-023-02277-2","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,10]]},"assertion":[{"value":"29 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"53"}}